Literature DB >> 10674914

Epstein-Barr virus-associated high-grade anaplastic plasmacytoma in a renal transplant patient.

H A Papadaki1, K Stefanaki, P Kanavaros, P Katonis, H Papastathi, W Valatas, K Stylianoy, G D Eliopoulos.   

Abstract

Allograft transplant patients have an increased risk of developing polyclonal or monoclonal lymphoproliferative disorders, but high-grade anaplastic plasmacytomas are extremely rare in these patients. We present a renal transplant patient who developed multiple extramedullary high-grade anaplastic plasmacytomas in the oral cavity, the left maxillary antrum, the scalp, the thigh and the upper abdominal wall with no evidence of diffuse bone marrow infiltration. Epstein-Barr virus (EBV) mRNA transcripts were detected within the myeloma cells by in situ hybridization using EBER1-2 probes. Following discontinuation of immunosuppression applied, the patient was treated with a cyclophosphamide-prednisone regimen followed by local irradiation, and a complete remission was achieved within four weeks. We concluded that EBV-associated high-grade anaplastic plasmacytomas constitute one more type of post-transplant lymphoproliferative disorder, and that despite their characterization as highly malignant neoplasms, their clinical behavior is not always aggressive.

Entities:  

Mesh:

Year:  2000        PMID: 10674914     DOI: 10.3109/10428190009148863

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  6 in total

1.  Plasmacytoma-like post-transplantation lymphoproliferative disease occurring in a cardiac allograft: a case report and review of the literature.

Authors:  Tzu-Fei Wang; Jonathan L Klein; Pamela K Woodard; Anjum Hassan; Susan M Joseph; Gregory A Ewald; Geoffrey L Uy
Journal:  J Clin Oncol       Date:  2012-06-18       Impact factor: 44.544

Review 2.  Epstein-Barr virus-positive multiple myeloma developing after immunosuppressant therapy for rheumatoid arthritis: a case report and review of literature.

Authors:  Yasunobu Sekiguchi; Asami Shimada; Kunimoto Ichikawa; Mutsumi Wakabayashi; Keiji Sugimoto; Keigo Ikeda; Iwao Sekikawa; Shigeki Tomita; Hiroshi Izumi; Noriko Nakamura; Tomohiro Sawada; Yasunori Ohta; Norio Komatsu; Masaaki Noguchi
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

Review 3.  Posttransplant lymphoproliferative disease: pathogenesis, monitoring, and therapy.

Authors:  Richard F Ambinder
Journal:  Curr Oncol Rep       Date:  2003-09       Impact factor: 5.075

Review 4.  Plasma cell neoplasia after kidney transplantation: French cohort series and review of the literature.

Authors:  Raphaël Kormann; Hélène François; Thibault Moles; Jacques Dantal; Nassim Kamar; Karine Moreau; Thomas Bachelet; Anne-Elisabeth Heng; Antoine Garstka; Charlotte Colosio; Didier Ducloux; Johnny Sayegh; Benjamin Savenkoff; Denis Viglietti; Rebecca Sberro; Eric Rondeau; Julie Peltier
Journal:  PLoS One       Date:  2017-06-21       Impact factor: 3.240

5.  Plasma cell neoplasms in US solid organ transplant recipients.

Authors:  Eric A Engels; Christina A Clarke; Ruth M Pfeiffer; Charles F Lynch; Dennis D Weisenburger; Todd M Gibson; Ola Landgren; Lindsay M Morton
Journal:  Am J Transplant       Date:  2013-05-01       Impact factor: 9.369

Review 6.  An Algorithmic Immunohistochemical Approach to Define Tumor Type and Assign Site of Origin.

Authors:  Andrew M Bellizzi
Journal:  Adv Anat Pathol       Date:  2020-05       Impact factor: 4.571

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.